Scientific Program

OPENING OPENING SPEECHES
09:00 - 10:00

Mustafa GÜZEL, Congress President

Türkan YİĞİTBAŞI, Congress President

Mustafa CAMGÖZ, Honorary President

Ömer CERAN, Rector of İstanbul Medipol University

Sabahattin AYDIN, Deputy Minister of the Ministry of Health

Fahrettin KOCA, Minister of Health of Turkey (In case of his presence)

KEYNOTE-1  
Moderators Mustafa CAMGÖZ, Imperial College London - Seyhan ALTUN, İstanbul Kültür University
10:00 - 10:40

Tumor Microenvironment Acidity As A Driver of Cancer Development

Stine PEDERSEN, Copenhagen University

10:40 - 10:50 BREAK
SESSION 1 CANCER AND ION CHANNELS - 1
Chairs

Mustafa CAMGÖZ, Imperial College London - Seyhan ALTUN, İstanbul Kültür University

10:50 - 11:15

Oncochannelopathies of Prostate Cancer

Natalia PREVERSKAYA, University of Lille

11:15 - 11:40

Targeted silencing of Na V 1.5 channel suppresses cell proliferation and invasion in ovarian cancer cells

Mümin Alper ERDOĞAN, İzmir Katip Çelebi University

11:40 - 11:50

Discussion

SESSION 2 COVID-19 AND CANCER
Chairs

Recep ÖZTÜRK, İstanbul University -  Ali MERT, İstanbul Medipol University

12:10 - 12:35

COVID-19 Vaccines and Cancer

Hakan AKBULUT, Ankara University

12:35 - 13:00

Development of VLP-Based Vaccine to Prevent COVID-19

İhsan GÜRSEL, Bilkent University

13:00 - 13:25

IL-1 Blockade in the treatment of viral infections and cancers

Ahmet GÜL, İstanbul University

13:25 - 13:35 Discussion
13:35 - 13:45 BREAK
SESSION 3

TUMOR IMMUNOLOGY

Chairs Dicle GÜÇ, Hacettepe University  - Özlem GÖKSEL, Ege University
13:45 - 14:10

Natural Killer Cells in Cancer Immunotherapy

Tolga SÜTLÜ, Boğaziçi University

14:10 - 14:35

Immune Regulatory Roles of B Cells in Non-Small Cell Lung Cancer

Deniz DURALI, İstanbul Medipol University

14:35 - 14:40 Discussion
14:40 - 14:45 BREAK
SATELLITE SYMPOSIUM ANAMED & ANALYTIC GROUP
14:45 - 15:15

Scalable Technology for Cancer Drug Delivering Nanoparticle Manufacturing 

Yang SU

15:15 - 15:20 BREAK
SESSION 4

DRUG DISCOVERY AND DEVELOPMENT-1

Chairs Ceyda ACILAN AYHAN, Koç University -  Hülya AYAR KAYALI, Dokuz Eylül University
15:20 - 15:45

Development of Targeted Therapeutics for Highly Aggressive Cancers

Bülent ÖZPOLAT, MD Anderson Cancer Center

15:45 - 16:10

Development of Targeted Therapies for Ewing Sarcoma

Aykut ÜREN, Georgetown University

16:10 - 16:35

Targeting Cancer at the Nuclear Pore

Ramzi MOHAMMAD, Wayne State University

16:35 - 16:45 Tartışma
16:45 - 17:00 BREAK
PRESIDENTIAL LECTURE  
Moderator Mustafa CAMGÖZ, Imperial College London
17:00 - 17:50

Epigenetic Programs the Tumor Progression

Robert WEINBERG, Whitehead Biomedical Research Institute

 

Sponsored by   

 

 

 

KEYNOTE-2  
Moderators Ender ELLİDOKUZ, Dokuz Eylül University - Ertuğrul KILIÇ, İstanbul Medipol University
08:30 - 09:10

Dietary Control of Stem Cells in Physiology and Disease

Ömer H. YILMAZ, Koch Institute

09:10 - 09:20 BREAK
SESSION 8

DIABETES AND CANCER METABOLISM

Chairs Ender ELLİDOKUZ, Dokuz Eylül University - Ertuğrul KILIÇ, İstanbul Medipol University
09:20 - 09:45

Targeting PKLR for treatment of Liver Cancer and NAFLD

Adil MARDİNOĞLU, King's College

09:45 - 10:10

Cancer as Metabolic Disease: New Horizons and Roadmaps in Cancer Therapeutics

Mustafa GÜZEL, İstanbul Medipol University

10:10 - 10:20 Tartışma
10:20 - 10:30 BREAK
SESSION 9 CANCER AND CELL DEATH
Chairs Hasan TÜRKEZ, Atatürk University - Semra DEMOKAN, İstanbul University
10:30 - 10:55

Autophagy and cancer

Devrim GÖZÜAÇIK, Koç University

10:55 - 11:20

Hsa-miR-21-3p Influences the Progression of Breast Cancer

Arsalan AMIRFALLAH, University of Iceland

11:20 - 11:45

Innovative Approaches to Build Theranostic Nanoplatforms

S. Sibel ERDEM, İstanbul Medipol University 

11:45 - 11:55 Discussion
11:55 - 12:15 BREAK
SESSION 10

CLINICAL ASPECTS OF CANCER IMMUNOTHERAPY

Chairs Deniz SARGIN, İstanbul Medipol University -  Ebru IŞIK ALTURFAN, Marmara University 
12:15 - 12:40

Immunotherapy: CAR T cell therapy in Pediatric Patients with Hematologic Malignancies

Sema ANAK, İstanbul Medipol University 

12:40 - 13:05

Clinical Aspects of Cancer Research

Ömür Gökmen SEVİNDİK, İstanbul Medipol University 

13:05 - 13:30

Immunotherapy: Immune Checkpoint Inhibitors in Malignancies

Hüseyin Saffet BEKÖZ, İstanbul Medipol University 

13:30 - 13:40 Discussion
13:40 - 14:15 BREAK
SESSION 11 DNA REPAIR MECHANISM IN CANCER
Chairs Leylagül KAYNAR, İstanbul Medipol University  -  Mehtap KUTLU, Eskişehir Technical University 
14:15 - 14:40

Circadian Clock and Cancer

Halil KAVAKLI, Koç University 

14:40 - 15:05

Biological Clock and DNA Damage Response

Nuri ÖZTÜRK, Gebze Technical University

15:05 - 15:15 Discussion
15:15 - 15:25 BREAK
SESSION 12

TUMOR MICROENVIRONMENT AND METASTASIS

Chairs Lale DOĞAN, Hacettepe University - Gürkan ÖZTÜRK, İstanbul Medipol University
15:25 - 15:50

Nanoscale Fluoropyrimidine Polymers for Overcoming Limitations of Existing Therapies for Gastrointestinal Malignancies

William GMEINER, Wake Forest University

15:50 - 16:15

The Significance of Myeloid Cells in the Tumor Microenvironment and Pre-Metastatic Niche

Hasan KÖRKAYA, Augusta University

16:15 - 16:40

Adipose Niche Reprograms the Metastatic Machinery of Cancer Cells

Giorgio STASSI, University of Palermo

16:40 - 17:05

Targeting Tumor Microenvironment for the Lung Cancer Treatment

Abdullah KARADAĞ, TUBITAK Gene Engineering and Biotechnology Institute

17:05 - 17:15 Discusson
17:15 - 17:25 BREAK
KEYNOTE - 3  
Moderators Erdal BEDİR, İzmir Instıtute of Technology -  Gülgün OKTAY, Dokuz Eylül University
17:25 - 18:05

Endogenous Bioelectric Signals as a New Target for Cancer Medicine

Michael LEVIN, Tufts University

18:05 - 18:15 ARA
SESSION 13  
Chairs

Erdal BEDİR, İzmir Instıtute of Technology -  Gülgün OKTAY, Dokuz Eylül University

18:15 - 18:40

Ion Channel Complexes: A New Paradigm in Cancer Research

Annarosa ARCANGELI, University of Florence

18:40 - 19:05

Modulator role of selenium on cisplatin-induced mitochondrial oxidative stress and neuropathic pain: Focus on TRPM2 and TRPV1 channels

Mustafa NAZIROĞLU, Süleyman Demirel University

19:05 - 19:15 Discussion

 

 

 

KEYNOTE-4  
Moderators Esra ÇAĞAVİ, İstanbul Medipol University - Ahmet AYDIN, Yeditepe University
08:30 - 09:10

Carbonic Anhydrase Inhibitors: Theragnostic Agents for Hypoxic Tumors 

Claudiu SUPURAN, University of Florence

SESSION 17 DRUG DISCOVERY AND DEVELOPMENT-2
Chairs Esra ÇAĞAVİ, İstanbul Medipol University - Ahmet AYDIN, Yeditepe University
09:20 - 09:45

Overcoming drug resistance: Identification of molecular action mechanisms of new generation therapeutics in cancer therapy

Elif Damla ARISAN, Gebze Technical University

09:45 - 10:10

Antibody-Based Approaches for Cancer Treatment and Diagnosis

Sibel KALYONCU UZUNLAR, Izmir Biomedicine and genome Center

10:10 - 10:20

Discussion

10:20 - 10:30 BREAK
SESSION 18 FUTURE OF CLINICAL ONCOLOGY
Chair Serdar TURHAL, Turkish Medical Oncology Association - Mahmut GÜMÜŞ, Istanbul Medeniyet University
10:30 - 10:55

An overew of pediatric hematooncology from today to the future with cases

Murat ELLİ, İstanbul Medipol University

10:55 - 11:20

Predictive and prognostic factors in the era of immunooncology

Ahmet BİLİCİ, İstanbul Medipol University

11:20 - 11:45

Changing paradigma in clinical oncology: what are we expecting from the future? 

Ömer Fatih ÖLMEZ, İstanbul Medipol University

11:45 - 11:55 Tartışma
11:55 - 12:05 BREAK
SESSION 19 CANCER AND STEM CELLS
Chairs Emin KANSU, Thomas Jefferson University - Tunç AKKOÇ, Marmara University
12:05 - 12:30

Cancer Immunology

Tunç AKKOÇ, Marmara University

12:30 - 12:55

New Era for Cancer Therapies: Bioengineered stem cells as delivery vehicles 

Nihal KARAKAŞ, Istanbul Medipol University

12:55 - 13:20

Liver Cancer Stem Cells: Two- and Three-Dimensional Cell Culture Studies, Organoids

Ranan GÜLHAN AKTAŞ, Maltepe University

13:20 - 13:30 Discussion
13:30 - 13:40 BREAK
SESSION 20 NATURAL AND INTEGRATED APPROACHES
Chairs Hülya ELLİDOKUZ, Dokuz Eylül University -  Tuncay GÖKSEL, Ege University
14:40 - 15:05

NGS based personalized cancer treatment/ Molecular based aproach to cancer

Mutlu DEMİRAY, Medicana Ataşehir Hospital

15:05 - 15:30

The place of plants and bee products in cancer treatment

Abdürrahim KOÇYİĞİT, Bezm-i Alem University

15:30 - 15:40 Discussion
15:40 - 15:50 BREAK
KEYNOTE-5  
Moderators Hülya ELLİDOKUZ, Dokuz Eylül University -  Tuncay GÖKSEL, Ege University
15:50 - 16:30

Integrative Oncology in Prostate Cancer

Ömer KÜÇÜK, Emory University

16:30 - 16:40 BREAK
SESSION 21 DRUG RESISTANCE IN CANCER
Chairs Ayhan TAŞTEKİN, İstanbul Medipol University- Özcan YILDIZ, İstanbul Medipol University
16:40 - 17:05

From Mechanisms of Drug Resistance to Drug Discovery in the Era of Precision Medicine

Özgür ŞAHİN, South Carolina University

17:05 - 17:30

Differential expression of MEIS1/2/3 correlates with prostate cancer viability in response to MEISi treatment

Fatih KOCABAŞ, Yeditepe University

17:30 - 17:55

Interactome analysis of protein-protein interaction networks reveals critical signaling hubs for therapeutic targeting in cancer cells

Gizem DİNLER DOĞANAY, İstanbul Technical University

17:55 - 18:05 Discussion
18:05 - 18:15 BREAK
KEYNOTE-6  
Moderators Türkan YİĞİTBAŞI, İstanbul Medipol University - Yasemin BAŞBINAR, Dokuz Eylül University
18:15 - 18:55

Sphingolipid Metabolism and Signaling in Cancer Therapy

Besim ÖĞRETMEN, Medical University of South Carolina

18:55 - 19:05 BREAK
SESSION 22 CANCER METABOLISM
Chairs Türkan YİĞİTBAŞI, İstanbul Medipol University - Yasemin BAŞBINAR, Dokuz Eylül University
19:05 - 19:30

Systematic Approaches to Study Cancer Cell Metabolism

Kıvanç BİRSOY, Rockefeller University

19:30 - 19:55

Ceramide Metabolism in Tumor Metastasis

Salih GENCER, İstanbul Medipol University

19:55 - 20:05 Discussion
20:05 - 20:30 Presidential Awards & Closing Remarks